Table 2 Clinical characteristics and treatments of 12 NSCLC patients
Patient | Sex | Age (y) | Pathologic Typing | Pathologic Stage | Means of treatment |
|---|---|---|---|---|---|
1 | F | 64 | LCLC | II | chemo-therapy for 7 days |
2 | M | 70 | Squ | III | chemo-therapy for 7 days |
3 | M | 70 | Squ | III | chemo-therapy for 7 days |
4 | F | 36 | Squ | III | chemo-therapy for 7 days |
5 | M | 75 | Ad | IV | chemo-therapy for 7 days |
6 | M | 62 | Squ | IV | interventional therapy |
7 | M | 65 | Ad | II | operation |
8 | F | 58 | Squ | IV | chemo-therapy for 7 days |
9 | M | 55 | Squ | III | interventional therapy |
10 | M | 58 | Squ | II | operation |
11 | M | 68 | Ad | I | operation |
12 | M | 61 | Ad | II | operation |